209 related articles for article (PubMed ID: 25451745)
1. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
Ha ES; Ok J; Noh J; Jeong HY; Choo GH; Jung YS; Baek IH; Kim JS; Cho W; Hwang SJ; Kim MS
Int J Biol Macromol; 2015 Jan; 72():1473-8. PubMed ID: 25451745
[TBL] [Abstract][Full Text] [Related]
2. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
3. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
Ha ES; Choo GH; Baek IH; Kim MS
Molecules; 2014 Dec; 19(12):20325-39. PubMed ID: 25486246
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
5. Impact of surfactants on the crystal growth of amorphous celecoxib.
Mosquera-Giraldo LI; Trasi NS; Taylor LS
Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
[TBL] [Abstract][Full Text] [Related]
6. Dissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactant.
Ha ES; Choo GH; Baek IH; Kim JS; Cho W; Jung YS; Jin SE; Hwang SJ; Kim MS
Int J Biol Macromol; 2015 Jan; 72():218-22. PubMed ID: 25159878
[TBL] [Abstract][Full Text] [Related]
7. The use of spray-drying to enhance celecoxib solubility.
Fouad EA; El-Badry M; Mahrous GM; Alanazi FK; Neau SH; Alsarra IA
Drug Dev Ind Pharm; 2011 Dec; 37(12):1463-72. PubMed ID: 21707230
[TBL] [Abstract][Full Text] [Related]
8. Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization.
Ha ES; Baek IH; Yoo JW; Jung Y; Kim MS
Drug Des Devel Ther; 2015; 9():3257-66. PubMed ID: 26150699
[TBL] [Abstract][Full Text] [Related]
9. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
[TBL] [Abstract][Full Text] [Related]
10. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
11. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Ishak RA; Osman R
Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
[TBL] [Abstract][Full Text] [Related]
12. Impact of HPMC on the physical properties of spray-congealed PEG microparticles and its swelling effect on rifampicin dissolution.
Oh CM; Ru Shan Siow C; Heng PW; Chan LW
Drug Dev Ind Pharm; 2016; 42(3):403-11. PubMed ID: 26165248
[TBL] [Abstract][Full Text] [Related]
13. Influence of Hydroxypropyl Methylcellulose on Metronidazole Crystallinity in Spray-Congealed Polyethylene Glycol Microparticles and Its Impact with Various Additives on Metronidazole Release.
Oh CM; Heng PW; Chan LW
AAPS PharmSciTech; 2015 Dec; 16(6):1357-67. PubMed ID: 25933626
[TBL] [Abstract][Full Text] [Related]
14. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
Goddeeris C; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
[TBL] [Abstract][Full Text] [Related]
15. The roles of a surfactant in zein-HPMC blend solid dispersions for improving drug delivery.
Ngo HV; Tran PHL; Lee BJ; Tran TTD
Int J Pharm; 2019 May; 563():169-173. PubMed ID: 30954672
[TBL] [Abstract][Full Text] [Related]
16. Supersaturatable formulations for the enhanced oral absorption of sirolimus.
Kim MS; Kim JS; Cho W; Cha KH; Park HJ; Park J; Hwang SJ
Int J Pharm; 2013 Mar; 445(1-2):108-16. PubMed ID: 23396259
[TBL] [Abstract][Full Text] [Related]
17. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F
Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel Napadisilate Monohydrate Loaded Surface-Modified Solid Dispersion: Physicochemical Characterization and in Vivo Evaluation.
Kim YH; Kim DW; Kwon MS; Cho KH; Kim JO; Yong CS; Choi HG
Biol Pharm Bull; 2015; 38(7):1033-40. PubMed ID: 26133713
[TBL] [Abstract][Full Text] [Related]
19. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
20. Preparation and physicochemical and preclinical evaluations of recrystallized celecoxib.
Mutalik S; Usha N; Ranjith AK; Umesh S; Musmade P; Anup N
PDA J Pharm Sci Technol; 2007; 61(5):362-74. PubMed ID: 18047175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
